Incorporation of a tetrameric M2e antigen enhances cross-protective efficacy of an inactivated H5N1 avian influenza vaccine

Open Access

Issue		BIO Web Conf. Volume 229, 2026 The 3^rd International Conference of Advanced Veterinary Science and Technologies for Sustainable Development (3^rd ICAVESS 2025)


Article Number		03001
Number of page(s)		13
Section		Managing Emerging Diseases
DOI		https://doi.org/10.1051/bioconf/202622903001
Published online		12 March 2026

World Health Organization (WHO), Influenza at the human–animal interface: Summary and assessment, 13 December 2024–20 January 2025 (2025). https://www.who.int/publications/m/item/influenza-at-the-human-animal-interface-summary-and-assessment--20-january-2025 [Google Scholar]
Food and Agriculture Organization (FAO), Avian Influenza Global Situation Update – September 2025 (2025). https://www.fao.org/animal-health/situation-updates/global-aiv-with-zoonotic-potential/en [Google Scholar]
N.L.P.I. Dharmayanti, D.A. Hewajuli, A. Ratnawati, R. Hartawan, Genetic diversity of the H5N1 viruses in live bird markets, Indonesia. J. Vet. Sci. 21, e56 (2020). https://doi.org/10.4142/jvs.2020.21.e56 [Google Scholar]
D. Karo-karo, R. Bodewes, H. Wibawa, M. Artika, E. Pribadi, D. Diyantoro, et al., Reassortments among Avian Influenza A(H5N1) Viruses Circulating in Indonesia, 2015–2016. Emerg. Infect. Dis. 25, 465-472 (2019). https://doi.org/10.3201/eid2503.180167 [Google Scholar]
H. Wibawa, Avian Influenza Disease Update, Control Strategy, and Poultry Vaccination in Indonesia. National Reference Laboratory for Avian Influenza, Directorate General-Livestock & Animal Health Services, Ministry of Agriculture, Republic of Indonesia (2022). https://rr-asia.woah.org/app/uploads/2022/12/3-c-avian-disease-update_indonesia_hendra.pdf [Google Scholar]
D.J. Smith, A.S. Lapedes, J.C. de Jong, T.M. Bestebroer, G.F. Rimmelzwaan, A.D. Osterhaus, R.A. Fouchier, Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371-6 (2004). https://doi.org/10.1126/science.1097211 [CrossRef] [PubMed] [Google Scholar]
X. Xing, J. Shi, P. Cui, C. Yan, Y. Zhang, Y. Zhang, C. Wang, Y. Chen, X. Zeng, G. Tian, L. Liu, Y. Guan, C. Li, Y. Suzuki, G. Deng, H. Chen, Evolution and biological characterization of H5N1 influenza viruses bearing the clade 2.3.2.1 hemagglutinin gene. Emerg. Microbes. Infect. 13, 2284294 (2024). https://doi.org/10.1080/22221751.2023.2284294. [Google Scholar]
V. Guyonnet, A.R. Peters, Are current avian influenza vaccines a solution for smallholder poultry farmers? Gates Open Res. 4, 122 (2020). https://doi.org/10.12688/gatesopenres.13171.1 [Google Scholar]
EFSA Panel on Animal Health and Welfare (AHAW), Vaccination of poultry against highly pathogenic avian influenza. EFSA Journal 21, 8271 (2023). https://doi.org/10.2903/j.efsa.2023.8271 [Google Scholar]
S. Neirynck, T. Deroo, X. Saelens, P. Vanlandschoot, W.M. Jou, W. Fiers, A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5, 1157-63 (1999). https://doi.org/10.1038/13484 [Google Scholar]
L. Deng, K.J. Cho, W. Fiers, X. Saelens, M2e-based universal influenza A vaccines. Vaccines (Basel) 3, 105-36 (2015). https://doi.org/10.3390/vaccines3010105 [Google Scholar]
D. Mezhenskaya, I. Isakova-Sivak, L. Rudenko, M2e-based universal influenza vaccines: a historical overview and new approaches to development. J. Biomed. Sci. 26, 76 (2019). https://doi.org/10.1186/s12929-019-0572-3 [Google Scholar]
W.C. Wang, E.E. Sayedahmed, S. Sambhara, S.K. Mittal, Progress towards the development of a universal influenza vaccine. Viruses 14, 1684 (2022). https://doi.org/10.3390/v14081684 [CrossRef] [PubMed] [Google Scholar]
A. Jegerlehner, N. Schmitz, T. Storni, M.F. Bachmann, Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol. 172, 5598-605 (2004). https://doi.org/10.4049/jimmunol.172.9.5598 [Google Scholar]
Y.N. Lee, M.C. Kim, Y.T. Lee, Y.J. Kim, S.M. Kang, Mechanisms of cross-protection by influenza virus M2-based vaccines. Immune Netw. 15, 213-21 (2015). https://doi.org/10.4110/in.2015.15.5.213 [Google Scholar]
X. Mu, K. Hu, M. Shen, N. Kong, C. Fu, W. Yan, A. Wei, Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA). J. Virol. Methods 228, 84-90 (2016). https://doi.org/10.1016/j.jviromet.2015.11.014 [Google Scholar]
B.M. Song, H.M. Kang, E.K. Lee, S.C. Jung, M.C. Kim, Y.N. Lee, S.M. Kang, Y.J. Lee. Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens. Vaccine 34, 678-686 (2016). https://doi.org/10.1016/j.vaccine.2015.11.074 [Google Scholar]
A.M. Andersson, K.O. Håkansson, B.A. Jensen, D. Christensen, P. Andersen, A.R. Thomsen, J.P. Christensen, Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. PLoS One 7, e46395 (2012). https://doi.org/10.1371/journal.pone.0046395 [Google Scholar]
L.A. Stepanova, R.Y. Kotlyarov, A.A. Kovaleva, M.V. Potapchuk, A.V. Korotkov, M.V. Sergeeva, M.A. Kasianenko, V.V. Kuprianov, N.V. Ravin, L.M. Tsybalova, K.G. Skryabin, O.I. Kiselev, Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin. PLoS One 10, e0119520 (2015). https://doi.org/10.1371/journal.pone.0119520 [Google Scholar]
J. W. Huleatt, V. Nakaar, P. Desai, et al., Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26, 201–214 (2008). https://doi.org/10.1016/j.vaccine.2007.10.062 [Google Scholar]
World Organisation for Animal Health (WOAH), Avian influenza (infection with avian influenza viruses), Terrestrial Manual, Chapter 3.3.4 (2023). https://www.woah.org/fileadmin/Home/eng/Health_standards/tahm/3.03.04_AI.pdf [Google Scholar]
A. Kandeil, Y. Moatasim, M. R. Gomaa, et al., Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses. Vaccine 34, 218–224 (2016). https://doi.org/10.1016/j.vaccine.2015.11.037 [Google Scholar]
J.G. Marblestone, S.C. Edavettal, Y. Lim, P. Lim, X. Zuo, T.R. Butt, Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO. Protein Sci. 15, 182-9 (2006). https://doi.org/10.1110/ps.051812706 [Google Scholar]
E.A. Blokhina, E.S. Mardanova, A.A Zykova, L.A. Stepanova, M.A. Shuklina, L.M. Tsybalova, N.V. Ravin, Plant-produced nanoparticles based on artificial self-assembling peptide bearing the influenza M2e epitope. Plants (Basel) 12, 2228 (2023). https://doi.org/10.3390/plants12112228 [Google Scholar]
Y. Lu, J.P. Welsh, W. Chan, J.R. Swartz, Escherichia coli-based cell free production of flagellin and ordered flagellin display on virus-like particles. Biotechnol. Bioeng. 110, 2073-85 (2013). https://doi.org/10.1002/bit.24903 [Google Scholar]
Y. Lu, J.R. Swartz, Functional properties of flagellin as a stimulator of innate immunity. Sci. Rep. 6, 18379 (2016). https://doi.org/10.1038/srep18379 [Google Scholar]
V.M. Bolanos-Garcia, O.R. Davies, Structural analysis and classification of native proteins from E. coli commonly co-purified by immobilised metal affinity chromatography. Biochim. Biophys. Acta 1760, 1304-13 (2006). https://doi.org/10.1016/j.bbagen.2006.03.027 [Google Scholar]
D.T. O'Hagan, R. van der Most, R.N. Lodaya, M. Coccia, G. Lofano, “World in motion” – emulsion adjuvants rising to meet the pandemic challenges. npj Vaccines 6, 158 (2021). https://doi.org/10.1038/s41541-021-00418-0 [Google Scholar]
M. Jafari, M. Moghaddam Pour, M. Taghizadeh, S. Masoudi, Z. Bayat, Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens. Artif. Cells Nanomed. Biotechnol. 45, 84-89 (2017). https://doi.org/10.3109/21691401.2015.1129626 [Google Scholar]
T. Zhao, Y. Cai, Y. Jiang. et al., Vaccine adjuvants: mechanisms and platforms. Sig. Transduct. Target. Ther. 8, 283 (2023). https://doi.org/10.1038/s41392-023-01557-7 [Google Scholar]
H. J. Kang, K. B. Chu, D. H. Lee, et al., Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs. PLoS One 14, e0216871 (2019). https://doi.org/10.1371/journal.pone.0216871 [Google Scholar]
B. R. Park, J. Subbiah, K. H. Kim, et al., Enhanced cross protection by hetero prime–boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin–M2e epitopes. Virology 566, 143–152 (2022). https://doi.org/10.1016/j.virol.2021.12.003 [Google Scholar]
X. Saelens, The role of matrix protein 2 ectodomain in the development of universal influenza vaccines. J. Infect. Dis. 219, S68-S74 (2019). https://doi.org/10.1093/infdis/jiz003 [Google Scholar]
M.P. Tan, W.S. Tan, N.B Mohamed Alitheen, W.B. Yap, M2e-based influenza vaccines with nucleoprotein: a review. Vaccines (Basel) 9, 739 (2021). https://doi.org/10.3390/vaccines9070739 [Google Scholar]
Q. Wang, Y. Zhang, P. Zou, M. Wang, W. Fu, J. She, Z. Song, J. Xu, J. Huang, F. Wu, Self-assembly M2e-based peptide nanovaccine confers broad protection against influenza viruses. Front. Microbiol. 11, 1961 (2020). https://doi.org/10.3389/fmicb.2020.01961 [Google Scholar]
M. Dabaghian, A.M. Latify, M. Tebianian, H. Nili, A.R. Ranjbar, A. Mirjalili, M. Mohammadi, R. Banihashemi, S.M. Ebrahimi, Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens. Vet. Microbiol. 174, 116-26 (2014). https://doi.org/10.1016/j.vetmic.2014.09.009 [Google Scholar]
C. Calzas, T.N. Alkie, M. Suderman, C. Embury-Hyatt, V. Khatri, R. Le Goffic, Y. Berhane, S. Bourgault, D. Archambault, C. Chevalier, M2e nanovaccines supplemented with recombinant hemagglutinin protect chickens against heterologous HPAI H5N1 challenge. npj Vaccines 9, 161 (2024). https://doi.org/10.1038/s41541-024-00944-7 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.